Welsis (WLSS) Revenue (2022 - 2023)
Welsis' quarterly Revenue came in at $2000.0 in Q4 2023, down 42.86% year-on-year from $3500.0 in Q4 2022, and down 91.3% quarter-over-quarter from $23000.0 in Q3 2023.
Welsis has reported Revenue for 2 years, with the latest figure at $2000.0 in Q4 2023.
- For the quarter ending Q4 2023, Revenue fell 42.86% year-over-year to $2000.0; the trailing twelve-month figure through Sep 2024 stood at $2000.0 (down 93.53% YoY), and the FY2024 full-year result was $2000.0, down 93.53% from the prior year.
- Revenue for Q4 2023 stood at $2000.0, down from $23000.0 in the prior quarter.
- The five-year high for Revenue was $23000.0 in Q3 2023, with the low at $2000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 835.95 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.61 Bn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 354.64 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 182.31 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 145.37 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 313.87 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 150.84 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 603.85 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 309.88 Mn |
| 10 | Welsis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 23,000.00 |
| Jun 30, 2023 | 4,400.00 |
| Dec 31, 2022 | 3,500.00 |